Pandemic (H1N1) 2009 virus infection: Persistent viral shedding after Oseltamivir treatment
Introduction
Although there are some published reports on the duration of shedding of seasonal influenza virus after treatment with Oseltamivir, data relevant to the pandemic (H1N1) 2009 virus strain in this regard are sparse.1 In early reports, the median time of pandemic (H1N1) 2009 viral shedding determined by reverse transcriptase polymerase chain reaction (RT-PCR) was 6 days.2, 3 The estimated duration of viral shedding is based upon seasonal influenza virus infection. Infected persons should be assumed to be contagious for up to 7 days from illness onset.1 Factors associated with duration of viral shedding after antiviral therapy have not been identified. Unlike with seasonal influenza strains, resistance to Oseltamivir has not yet become a major clinical problem. However, as the virus can potentially develop resistance to Oseltamivir at any time, surveillance for Oseltamivir resistance in pandemic (H1N1) 2009 viruses should continue.
In Thailand, the first case of laboratory-confirmed pandemic (H1N1) 2009 virus was found on May 12, 2009.4 The first case in south Thailand was identified in Thungsong Hospital, Nakhon Srithammarat Province on May 28, 2009. We followed patients seen at this hospital to determine clinical response, duration of viral shedding after treatment, and the development of resistant virus.
Section snippets
Materials and methods
The study was approved by the Ethical Committee of the Thoungsong Hospital. The pandemic (H1N1) 2009 positive patients were chosen from among the patients during the investigation and treatment of influenza like illness (ILI). The objective of the study was informed and written consents were obtained from the participants and/or parents.
Patient descriptions
During the study period (28 June–15 September 2009), 28,027 patients sought care at Thungsong Hospital with 4161 (15%) patients displaying respiratory tract infection and 2516 (60%) exhibiting ILI. Throat/nasal swabs were collected from 908 (36%) of 2516 patients with ILI. Three-hundred-fifty-seven (39%) comprising 122 inpatients and 235 outpatients, of 908 patients were confirmed cases. Follow-up serial samples were available from 91 patients. Among these, the median age was 16 (range 4
Discussion
We evaluated viral shedding as determined by rRT-PCR testing in confirmed cases of pandemic (H1N1) 2009 who had received Oseltamivir treatment. We found that 26% of confirmed pandemic (H1N1) 2009 patients remained rRT-PCR positive after 5 days of Oseltamivir administraton but did not detect any drug resistance. Twelve of 91 patients (13%) were found rRT-PCR positive approximately 11 days (range 10–16 days) after symptom onset (1–8 days after complete treatment). These findings are in accordance
Acknowledgments
This work was partially supported by Higher Education Research promotion and National Research University Project of Thailand, Office of the Higher Education Commission (HR 1155A), Thailand Research Fund and Center of Excellence in Clinical Virology. We would like to thank Prof. Sayomporn Sirinavin, Dr.Wiwan sanasuttipan, Dr Sonja Jolsen, Ms. Juree Nilma, Ms. Amornrat Roento, Ms. Suppalak Jitnatham, Ms. Jaru Suwanpakdee, Dr. Ratchaneekorn Songnui, Dr. Sukit Yamwong and the entire staff of the
References (16)
- et al.
Novel Influenza A (H1N1) outbreak at the U.S. Air Force Academy: epidemiology and viral shedding duration
Am J Prev Med
(2010) - et al.
Typing (A/B) and subtyping (H1/H3/H5) of influenza A viruses by multiplex real-time RT-PCR assays
J Virol Methods
(2008) - et al.
Ichhpujani RL.Pandemic Influenza A (H1N1) 2009 in India: duration of virus shedding in patients under antiviral treatment
Indian J Med Microbiol
(2011) - Centers for Diseases Control. Interim guidance on specimen collection, processing, and testing for patients with...
- et al.
Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China
N Eng J Med
(2009) - Department of Disease Control, Thailand Ministry of Public Health. The prevention of new strain of influenza H1N1,...
World Health Organization guidelines for pharmacological management of pandemic (H1N1) 2009 Influenza and other Influenza viruses
(20 August 2009)- United States Centers for Disease Control and Prevention. Updated interim recommendations for the use of antiviral...